GlassScriptPhysician profile
Zachary Pollock
NPI 1295379568
$2,252.00
in general payments reported to CMS, 2019-2025
18 companies · $582 in 2025
The $582 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $205 · 2022: $275 · 2023: $392 · 2024: $799 · 2025: $582.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,772.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,772.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $539.51 | 2022-2025 | |
| Regeneron Healthcare Solutions, INC. | $306.33 | 2021-2025 | Dupixent, Libtayo |
| Stryker Corporation | $276.40 | 2023-2025 | Clarifix Cryotherapy Device, Scopis Ent, Xpress Ent Dilation System |
| Glaxosmithkline, LLC. | $276.09 | 2021-2025 | Nucala |
| Inspire Medical Systems, INC. | $270.57 | 2024-2025 | Inspire |
| Optinose US, INC. | $237.81 | 2021-2025 | |
| Abbvie INC. | $54.54 | 2021 | |
| Hikma Pharmaceuticals USA | $48.46 | 2023-2024 | Ryaltris |
| Hologic Sales and Service, LLC | $47.10 | 2023-2025 | Coolseal Generator |
| Smith+Nephew, INC. | $35.06 | 2023 | Halo |
| Endogastric Solutions, INC | $30.15 | 2022 | |
| Phadia US INC. | $25.05 | 2021 | |
| Paratek Pharmaceuticals, INC. | $20.20 | 2025 | Xhance |
| Alk-Abello, INC | $20.08 | 2021 | |
| Azurity Pharmaceuticals, INC. | $19.61 | 2023 | Adthyza |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Pharmaceuticals America, INC. | $18.85 | 2022 | |
| Phathom Pharmaceuticals, INC. | $14.43 | 2024 | Voquezna |
| Intersect Ent, INC. | $11.76 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Zachary Pollock listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.